Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer

Medullary thyroid carcinoma (MTC) is a slow growing neuroendocrine (NE) tumor for which few treatment options are available. Its incidence is rising and mortality rates have remained unchanged for decades. Increasing the repertoire of available treatments is thus crucial to manage MTC progression. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Pozo, Karine, Zahler, Stefan, Ishimatsu, Keisuke, Carter, Angela M., Telange, Rahul, Tan, Chunfeng, Wang, Shuaijun, Pfragner, Roswitha, Fujimoto, Junya, Grubbs, Elizabeth Gardner, Takahashi, Masaya, Oltmann, Sarah C., Bibb, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340867/
https://www.ncbi.nlm.nih.gov/pubmed/30701022
http://dx.doi.org/10.18632/oncotarget.26480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340867/
https://www.ncbi.nlm.nih.gov/pubmed/30701022
http://dx.doi.org/10.18632/oncotarget.26480

Ejemplares similares